New Managing Director in Osstell AB

The board of Osstell has appointed Jonas Ohlsson as the MD of Osstell AB as a part of an expected future growth and expansion. Jonas Ohlsson starts May 11th 2010 and brings extensive experience from CEO assignments in fast-growing international medtech and life science companies specialising in innovative technologies and products. Jonas Ohlsson has previously worked in companies such as Mentice and Applied Biosystems. In addition to CEO roles, Jonas Ohlsson has many years of experience in international sales and marketing as well as  from other areas involving complex technologies and sales processes. He has a university degree in biochemistry and has also worked in the pharmaceutical industry for a few years.

“Jonas Ohlsson has a strong entrepreneurial drive with a solid commercial focus and displays a proven track record. We are convinced that he will be able to bring Osstell to further growth and success,” says Fredrik Lindgren, chairman of Osstell. He continues: “As Osstell is now well-positioned for growth and expansion, we feel that the company needs additional management resources with relevant experience. It is natural to strengthen the company in this way. Anders Petersson has done an excellent job in starting Osstell and developing it to the strong position it has now. The management change makes it possible for Anders Petersson to focus on the development of the company’s current and future products.”

“Osstell is an exciting company in a growing and dynamic market, with a technology base and products that bring opportunities for improved dental implant care,” emphasises Jonas Ohlsson, new MD of Osstell. “Better and more effective healthcare and the opportunity for improved patient quality are areas in which I have a very keen interest. I am looking forward to being a contributing part of Osstell AB and to developing it further through sustainable growth and expansion. The company is well-positioned for the future due to the focused and persistent work that has been put into product development and establishment of crucial key opinion leader relationships in the marketplace.” Jonas Ohlsson concludes: “The opportunities for international growth and expansion are very good – initially, we will focus on certain key markets of strategic importance.”

Jonas Ohlsson succeeds Anders Petersson, who will continue at Osstell in a new role as its COO, focusing on R&D and heading up all product-related activities, internal as well as external. Anders Petersson has been the MD since the company was founded in 1999.